Advanced technology for sorting and analyzing cells
High-throughput Full Spectrum Cell Sorter
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10431645
This study is all about getting a new, advanced cell sorting machine that will help scientists at UCSF better understand how cells behave in different diseases, which could lead to improved treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10431645 on ClinicalTrials.gov |
What this research studies
This research focuses on acquiring a state-of-the-art Full Spectrum Cell Sorter to enhance the capabilities of the UCSF Parnassus Flow Cytometry CoLab. The new instrument will allow researchers to sort and analyze individual cells with high precision, providing multidimensional data that can reveal important insights into cell behavior in various diseases. By utilizing advanced spectral technology, the sorter can analyze up to 40 different parameters simultaneously, which is crucial for understanding complex biological processes. This technology aims to support ongoing research into disease progression and treatment responses.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that involve complex cell population dynamics, such as cancer or autoimmune diseases.
Not a fit: Patients with stable, non-complex conditions that do not involve significant changes in cell populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the understanding of cell dynamics in diseases, leading to better-targeted therapies.
How similar studies have performed: Other research utilizing advanced cell sorting technologies has shown promising results in enhancing our understanding of cellular behaviors and improving treatment strategies.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NGUYEN, VINH — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: NGUYEN, VINH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.